IL41412A - Mineral salt preparation - Google Patents
Mineral salt preparationInfo
- Publication number
- IL41412A IL41412A IL41412A IL4141273A IL41412A IL 41412 A IL41412 A IL 41412A IL 41412 A IL41412 A IL 41412A IL 4141273 A IL4141273 A IL 4141273A IL 41412 A IL41412 A IL 41412A
- Authority
- IL
- Israel
- Prior art keywords
- weight
- parts
- sodium
- glycerophosphate
- magnesium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (1)
1. CLAIMS 1'' Process for the manufacture of a mineral salt preparation having delayed electrolyte release for the continuous replacement of mineral salts lost by bodily stress and in- ..· .ciieased- transpiration- as-well as-by^th"e~use "ofHiiur ics, which process comprises mixing salts which contain 5 to 80 parts by weight of calcium, 5 to 40 parts by weight of magnesium, 2 to 20 parts by weight of potassium and no sodium or less than 20 parts by weight of_ sodium in. a weight ratio which lies above 10 in ' relation -to the total weight of the preparation with a matrix suitable for imparting slow : . release characteristics and with additives which are customary in such preparations.' ; 2 · Process according to Claim 1 wherein calcium glycerophosphate, magnesium glycerophosphate, sodium chloride and potassium chloride are used as the salts. ' 3 "Process according to Claim' 1; or Claim- 2 .wherein citric acid is also added. 4. Process according to Claim 1 'Claim 2ior Claim. * ■ - i 1 — ' ■ 1 wherein 218.0 mg of calcium glycerophosphate, 227.5 mg of magnesium glycerophosphate, 42.35 mg of sodium chloride, 31.85 mg of potassium chloride and 45 mg of citric acid are used. I 5 η Mineral salt preparation having delayed electrolyte release for the continuous replacement of mineral salts lost by bodily stress and increased transpiration as well as by 41412/2 the use of diuretics, saia preparation containing a ( matrix suitable for importing slow release characteristics and, in the form of salts, 5 to 80 parts by weight of calcium, 5 to.40 parts by weight of magnesium, 2 to 20 parts by weight of potassium and no sodium or less than 20 parts by weight of sodium; the weight ratio of calcium, magnesium, potassium and sodium to the total weight of the preparation lying above 10 . 6. I Mineral salt preparation according to Claim 5.!in • 'i I - the form of tablets. ;7. Claim ~~6.j glycerophosphate, sodium chloride and potassium chloride. * Mineral salt preparation according to any one of toj η Inclusive which also contains citric acid. 9 Mineral salt preparation according to any one of Claims 5 to a ^inclusive which contains 218.0 mg of calcium glycerophosphate, 227.5 mg of magnesium glycerophosphate, 42.35 mg of sodium chloride, 31.85 mg of potassium chloride and 45 mg of citric acid.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH272072 | 1972-02-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL41412A0 IL41412A0 (en) | 1973-03-30 |
| IL41412A true IL41412A (en) | 1976-04-30 |
Family
ID=4240086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL41412A IL41412A (en) | 1972-02-25 | 1973-01-29 | Mineral salt preparation |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS4896717A (en) |
| AT (1) | AT322744B (en) |
| AU (1) | AU451930B2 (en) |
| BE (1) | BE795828A (en) |
| CA (1) | CA1023990A (en) |
| DE (1) | DE2305980A1 (en) |
| FR (1) | FR2173263B1 (en) |
| GB (1) | GB1356097A (en) |
| IE (1) | IE37292B1 (en) |
| IL (1) | IL41412A (en) |
| IT (1) | IT978459B (en) |
| NL (1) | NL7301863A (en) |
| PH (1) | PH10214A (en) |
| ZA (1) | ZA73467B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI834309A (en) * | 1983-11-24 | 1985-05-25 | Pharmaconsult Oy | SALTBLANDNING. |
| US4954349A (en) * | 1987-09-11 | 1990-09-04 | Ciba-Geigy Corporation | Oral magnesium and potassium compositions and use |
| CH677612A5 (en) * | 1987-09-11 | 1991-06-14 | Ciba Geigy Ag | |
| US5035898A (en) * | 1987-11-27 | 1991-07-30 | Schering Corporation | Potassium/magnesium supplement |
| FI120290B (en) * | 1996-12-30 | 2009-09-15 | Mirador Res Oy Ltd | A method for preparing seasoning compound, food ingredient, and food compositions that lower serum cholesterol |
| FR2773955B1 (en) * | 1998-01-26 | 2000-04-07 | Sanofi Sa | DIETETIC COMPOSITION IN THE FORM OF A SALT SUBSTITUTING TABLE SALT |
| FR2931359B1 (en) | 2008-05-20 | 2012-12-21 | Menvielle Bourg Fabienne Joanny | USE OF MATRIX FOR EXTENDED RELEASE MAGNESIUM ORAL DELIVERY, AND COMPOSITION CONTAINING SAME |
| FR2931361B1 (en) | 2008-05-20 | 2012-08-31 | Menvielle Bourg Fabienne Joanny | MAGNESIUM-BASED SYSTEM AND ITS USE IN COSMETICS |
| EP2813217A1 (en) | 2013-06-11 | 2014-12-17 | Fabienne Joanny Menvielle-Bourg | Composition for oral administration of magnesium, in association with a composition for the treatment of type 2 diabetes and its complications |
| FR3024019B1 (en) * | 2014-07-28 | 2017-11-24 | Yvan Erbs | FOOD SUPPLEMENT FOR IMPROVING THE FUNCTIONING OF LIVING CELLS AND ASSOCIATED METHOD |
| US20210196748A1 (en) * | 2019-12-30 | 2021-07-01 | Robert Olson | Composition and therapy for treatment of gag reflexes |
-
1973
- 1973-01-22 ZA ZA730467A patent/ZA73467B/en unknown
- 1973-01-25 IT IT19595/73A patent/IT978459B/en active
- 1973-01-25 AU AU51455/73A patent/AU451930B2/en not_active Expired
- 1973-01-29 IL IL41412A patent/IL41412A/en unknown
- 1973-02-07 DE DE2305980A patent/DE2305980A1/en not_active Withdrawn
- 1973-02-09 NL NL7301863A patent/NL7301863A/xx unknown
- 1973-02-16 PH PH14350*A patent/PH10214A/en unknown
- 1973-02-19 IE IE252/73A patent/IE37292B1/en unknown
- 1973-02-23 FR FR7306517A patent/FR2173263B1/fr not_active Expired
- 1973-02-23 CA CA164,470A patent/CA1023990A/en not_active Expired
- 1973-02-23 AT AT163273A patent/AT322744B/en not_active IP Right Cessation
- 1973-02-23 GB GB905473A patent/GB1356097A/en not_active Expired
- 1973-02-23 JP JP48021406A patent/JPS4896717A/ja active Pending
- 1973-02-23 BE BE795828D patent/BE795828A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2173263A1 (en) | 1973-10-05 |
| DE2305980A1 (en) | 1973-08-30 |
| BE795828A (en) | 1973-08-23 |
| PH10214A (en) | 1976-09-29 |
| NL7301863A (en) | 1973-08-28 |
| AU451930B2 (en) | 1974-08-22 |
| FR2173263B1 (en) | 1975-10-10 |
| AU5145573A (en) | 1974-07-25 |
| IE37292L (en) | 1973-08-25 |
| ZA73467B (en) | 1973-10-31 |
| GB1356097A (en) | 1974-06-12 |
| AT322744B (en) | 1975-06-10 |
| IL41412A0 (en) | 1973-03-30 |
| CA1023990A (en) | 1978-01-10 |
| IE37292B1 (en) | 1977-06-22 |
| IT978459B (en) | 1974-09-20 |
| JPS4896717A (en) | 1973-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870008580A (en) | Anti tartar toothpaste | |
| DE3065420D1 (en) | Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours | |
| IL41412A (en) | Mineral salt preparation | |
| ES8105746A1 (en) | (N-phosphonoacetyl-L-aspartato) (1,2 diaminocyclohexane) platinum (II) and the sodium, potassium or lithium salts thereof, their preparation and pharmaceutical compositions containing them. | |
| IL42313A (en) | Pharmaceutical composition containing glycyrrhetinic acid for the treatment of oesophagitis | |
| KR880012642A (en) | Crystalline human proinsulin and its preparation method | |
| ES8106003A1 (en) | Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them. | |
| US4139612A (en) | Process for making an aluminum phosphate gel | |
| IE831396L (en) | Oxytetracycline composition. | |
| DE3362246D1 (en) | Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle | |
| GB1415453A (en) | Composition and process for producing aquarium water having improved properties | |
| DE805769C (en) | Process for the preparation of injectable solutions of guaiacol | |
| ES472528A1 (en) | Derivatives of benzenesulfonamide, method for their preparation and pharmaceutical compositions containing them. | |
| IE32536B1 (en) | Orotic acid salt | |
| SU715548A1 (en) | Charge for producing refractory articles | |
| IE45768L (en) | Pharmaceutical composition | |
| KR900007423A (en) | Stable aqueous solution of primycin, pharmaceutical and cosmetic compositions containing the aqueous solution and preparation method thereof | |
| GB1509778A (en) | Pharmaceutical composition and dosage units thereof | |
| GB1072344A (en) | Medicated poultry composition | |
| IE45735L (en) | Glycinamides | |
| GB1274021A (en) | The manufacture of medicaments of which the excipient comprises a mixture of saccharose and glucose | |
| JPS5571702A (en) | Antitumorous glucan derivative, its preparation, and carcinostatic substance containing it | |
| GB1391449A (en) | Stabilisation of penicillins | |
| GB681264A (en) | Improvements in or relating to magnesium base alloys | |
| GB1292503A (en) | Formulation for treatment of psoriasis |